Search

everythinglearnresearchcommunity

for

Search:↓

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

PUVA treatment is effective and safe for alopecia areata.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Finasteride and dutasteride might lower melanoma risk.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

A new method helps detect androgen receptor movement in cells, aiding research on hair loss treatments.

Transepidermal drug delivery effectively treated areata alopecia with minimal side effects.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Azathioprine may help with severe hair loss, a new topical treatment could counteract hair thinning, and trichoscopy can diagnose hair-pulling disorder effectively.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

GSK-36 downregulation with UTMD improves plaque stability in atherosclerosis treatment.

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

Cuscuta reflexa extracts helped regrow hair in rats with drug-induced hair loss.

Mesotherapy with dutasteride improves hair growth and reduces symptoms in frontal fibrosing alopecia.

Polymeric nanoparticles with dutasteride may effectively treat hair loss by targeting hair follicles.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Intralesional steroids are more effective for hair regrowth in alopecia areata than NBUVB, but combining them doesn't improve results.

Ritlecitinib is a new treatment for severe hair loss in people 12 and older.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Cyproterone acetate can effectively treat idiopathic hirsutism, but ethinyl oestradiol and lynoestrenol may not always reduce hair growth.